New Delhi - International medical humanitarian organisation Doctors Without Borders (MSF) welcomes the decision by the Indian Patent Office to reject the product patent it had previously granted to pharmaceutical company Roche for the drug valganciclovir.
“For people living with HIV/AIDS in developing countries, accessing valganciclovir at Roche prices was difficult,” said Loon Gangte of the Delhi Network of Positive People (DNP+), one of the patient groups that filed an opposition to the patent. “The decision will provide much needed relief as it secures the way for generic competition, which is the most effective and sustainable way of bringing drug prices down.”
Borrie La Grange, MSF, South Africa +27 79 8722 950
Stephan Grosse Rueschkamp, MSF, Geneva +41 79 293 0270
Leena Menghaney, MSF, India +91 98 113 65 412